Back

Arrhythmic mitral valve prolapse detection using long-term ambulatory rhythm monitoring - the ALARM-PILOT study

29 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Syncope and bradycardia: risk stratification, treatment and outcome Ambulatory Electrocardiogram (ECG) Monitoring and Loop Recorders ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Eva Goethals

University Hospitals (UZ) Leuven, Leuven (Belgium)

7 More presentations in this session

Presentation thumbnail
Long-term outcomes of single atrial lead pacing in sick sinus syndrome: risk stratification using wenckebach block rate
Ms A. Takami (Tottori, JP)
Abstract Slides Video
Presentation thumbnail
Incidental findings of cardiac pauses in a nationwide atrial fibrillation screening trial: Insights from the NORSCREEN trial
Mr M. Haraldsen (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Beyond conduction disease: a prospective screening study of transthyretin cardiac amyloidosis in older patients referred for device therapy after syncope
Doctor C. Fumagalli (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Time to diagnosis and predictors of positive diagnostic findings in patients with unexplained syncope undergoing implantable loop recorder monitoring
Doctor A. Fonseca Vazao (Leiria, PT)
Abstract Slides Video
Presentation thumbnail
Can agentic AI match the gold standard? multi-agent risk stratification for syncope in the emergency department
Doctor A. Giaj Levra (Rozzano, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Syncope and bradycardia: risk stratification, treatment and outcome

The Event

Event poster

ESC Congress 2026

29 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Refining arrhythmic mitral valve prolapse definition by including left ventricular origin of arrhythmias: Insights from long-term cardiac monitoring
28 August 2026
thumbnail
Congress Presentation
Continuous ambulatory ECG monitoring of up to 14 days increases detection of high-risk ventricular tachyarrhythmias compared with the first 48 hours in hypertrophic cardiomyopathy
30 August 2026
thumbnail
Congress Presentation
Diagnostic yield of patient-triggered events during 14-days-electrocardiographic monitoring after transcatheter aortic valve implantation
30 August 2026
thumbnail
Congress Presentation
ASPIRED: Multi-centre open label randomised controlled trial of immediate enhanced ambulatory ECG monitoring versus standard monitoring in acute unexplained syncope patients
31 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources